103 related articles for article (PubMed ID: 6177659)
1. In vitro host range of equine infectious anemia virus.
Benton CV; Brown BL; Harshman JS; Gilden RV
Intervirology; 1981; 16(4):225-32. PubMed ID: 6177659
[TBL] [Abstract][Full Text] [Related]
2. The persistent infection of a canine thymus cell line by equine infectious anaemia virus and preliminary data on the production of viral antigens.
Bouillant AM; Nielsen K; Ruckerbauer GM; Samagh BS; Hare WC
J Virol Methods; 1986 Jul; 13(4):309-21. PubMed ID: 3018020
[TBL] [Abstract][Full Text] [Related]
3. Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection.
Du C; Ma J; Liu Q; Li YF; He XJ; Lin YZ; Wang XF; Meng QW; Wang X; Zhou JH
Retrovirology; 2015 Apr; 12():36. PubMed ID: 25928027
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the infection of equine fibroblasts by equine infectious anemia virus.
Klevjer-Anderson P; Cheevers WP; Crawford TB
Arch Virol; 1979; 60(3-4):279-89. PubMed ID: 228638
[TBL] [Abstract][Full Text] [Related]
5. Detection of proviral DNA in horse cells infected with equine infectious anemia virus.
Rice NR; Simek S; Ryder OA; Coggins L
J Virol; 1978 Jun; 26(3):577-83. PubMed ID: 209211
[TBL] [Abstract][Full Text] [Related]
6. Equine infectious anemia virus: evidence favoring classification as a retravirus.
Charman HP; Bladen S; Gilden RV; Coggins L
J Virol; 1976 Sep; 19(3):1073-9. PubMed ID: 61283
[TBL] [Abstract][Full Text] [Related]
7. Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.
Jin S; Issel CJ; Montelaro RC
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1120-9. PubMed ID: 15539516
[TBL] [Abstract][Full Text] [Related]
8. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
[TBL] [Abstract][Full Text] [Related]
9. Cellular and viral specificity of equine infectious anemia virus Tat transactivation.
Maury WJ; Carpenter S; Graves K; Chesebro B
Virology; 1994 May; 200(2):632-42. PubMed ID: 8178449
[TBL] [Abstract][Full Text] [Related]
10. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
[TBL] [Abstract][Full Text] [Related]
11. Equine monoclonal antibodies recognize common epitopes on variants of equine infectious anaemia virus.
Perryman LE; O'Rourke KI; Mason PH; McGuire TC
Immunology; 1990 Dec; 71(4):592-4. PubMed ID: 1703988
[TBL] [Abstract][Full Text] [Related]
12. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
[TBL] [Abstract][Full Text] [Related]
13. Proteomic alteration of equine monocyte-derived macrophages infected with equine infectious anemia virus.
Du C; Liu HF; Lin YZ; Wang XF; Ma J; Li YJ; Wang X; Zhou JH
Proteomics; 2015 Jun; 15(11):1843-58. PubMed ID: 25684102
[TBL] [Abstract][Full Text] [Related]
14. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Kong X; Zhou J
Arch Virol; 2011 Feb; 156(2):353-7. PubMed ID: 21136127
[TBL] [Abstract][Full Text] [Related]
15. Hybridoma cell lines secreting monoclonal antibodies against equine infectious anemia virus.
Horenstein AL; Glait HM; Koss A
J Virol Methods; 1987 Feb; 15(3):177-85. PubMed ID: 2435751
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of serum antibodies to equine infectious anemia virus reverse transcriptase.
DeVico AL; Issel CJ; Le Grice SF; Payne SL; Montelaro RC; Sarngadharan MG
AIDS Res Hum Retroviruses; 1993 Jan; 9(1):7-11. PubMed ID: 7678974
[TBL] [Abstract][Full Text] [Related]
17. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.
Craigo JK; Li F; Steckbeck JD; Durkin S; Howe L; Cook SJ; Issel C; Montelaro RC
J Virol; 2005 Mar; 79(5):2666-77. PubMed ID: 15708986
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus.
Montelaro RC; Robey WG; West MD; Issel CJ; Fischinger PJ
J Gen Virol; 1988 Jul; 69 ( Pt 7)():1711-7. PubMed ID: 2839603
[TBL] [Abstract][Full Text] [Related]
19. Propagation of equine infectious anemia virus in horse cell cultures.
Grădinaru DA; Stirbu C; Păltineanu D; Mironescu D; Manolescu N
Virologie; 1981; 32(1):23-7. PubMed ID: 6306910
[TBL] [Abstract][Full Text] [Related]
20. Serologically silent, occult equine infectious anemia virus (EIAV) infections in horses.
Ricotti S; Garcia MI; Veaute C; Bailat A; Lucca E; Cook RF; Cook SJ; Soutullo A
Vet Microbiol; 2016 May; 187():41-49. PubMed ID: 27066707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
